Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd

¥17.91As of Sun 8 Nov 2026, 12:00 UTC
SSE:600671Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE 6.45%
Drug Manufacturers (General)
Beta (5Y) 0.15
PE TTM 189.3
TSR TTM (5.09%)
Mkt cap ¥2.181B
ROIC 4.77%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥22
24.41%
(92.07%)
Hold 3|1|9|1|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.28
0.27
0.27
0.28
0.95%
(9.79%)
(7.87%)
(1.34%)
Revenue¥M
147.3
144.9
149.8
150.1
15.75%
13.76%
11.24%
6.03%
Peers (US$326.9M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.057
0.241
0.191
EBIT/Intx
2.345
0.193
0.234
Own earn%
(745.09)
(174.41)
(150.42)
Sh yield%
36.34
28.00
29.67
Owners
Insiders/Inst%
11.14
32.90
Short interest%
0.63
SBC / revenue%
3.74
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
4–10
$1 testx
0.0
Incr. ROIC%
−1